Stay updated on JARDIANCE Post-Marketing Surveillance in Korean Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the JARDIANCE Post-Marketing Surveillance in Korean Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JARDIANCE Post-Marketing Surveillance in Korean Type 2 Diabetes Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The updates appear to be visual/UI adjustments in the page header and layout, with core study details and outcomes unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:42:53.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:12:32.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.1%
    Check dated 2025-09-29T02:59:43.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:57:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T14:23:25.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has updated its content to include specific information about diabetes prevention and treatment, particularly focusing on Type 2 diabetes and the medication empagliflozin, while also changing the facility name and location details.
    Difference
    4%
    Check dated 2025-08-31T11:42:22.000Z thumbnail image

Stay in the know with updates to JARDIANCE Post-Marketing Surveillance in Korean Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JARDIANCE Post-Marketing Surveillance in Korean Type 2 Diabetes Clinical Trial page.